Data / Form D filings / Esperion Therapeutics, Inc.
Esperion Therapeutics, Inc.: Form D filings
Esperion Therapeutics, Inc., a pharmaceuticals company in Ann Arbor, MI, filed 4 Form D notices with the SEC between 2010 and 2014. The latest, on July 15, 2014, reports an offering of no set size with nothing sold yet to 1 investor.
Find out what Esperion Therapeutics, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 3891 Ranchero Drive, Suite 150, Ann Arbor, MI, 48108
- Phone
- (734) 887-3903
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1434868
The full lists. Form D filings in Michigan: 506 rows, $25.30, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jul 15, 2014 | New notice | Indefinite | $0 | Indefinite | 1 | Jun 30, 2014 | sec.gov |
| Apr 26, 2013 | New notice | Indefinite | $17,000,000 | Indefinite | 10 | Apr 11, 2013 | sec.gov |
| Feb 11, 2011 | Amendment | $38,760,000 | $27,950,000 | $10,810,000 | 9 | Apr 28, 2008 | sec.gov |
| Feb 12, 2010 | Amendment | $38,250,000 | $27,750,000 | $10,500,000 | 7 | Apr 28, 2008 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Antonio M. Gotto, Jr. | Director | |
| Tim M. Mayleben | Executive Officer, Director | |
| Gilbert S. Omenn | Director | |
| Daniel M. Janney | Director | |
| Dov A. Goldstein | Director | |
| Nicole S. Vitullo | Director | |
| Roger S. Newton | Director | |
| Patrick S. Enright | Director | |
| Mark E. McGovern | Director |
Other pharmaceuticals companies in Michigan that filed recently
- IMACS Working Capital Facility One LLC $200,000 · Sep 17, 2026
Every Form D from the week of Jul 14, 2014 · All recent filings in Michigan · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Esperion Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.